98%
921
2 minutes
20
Asthma affects 25 million people in the United States, and its prevalence is increasing. Access to care and adherence to prescribed asthma-treatment programs remain the principal formidable challenges for asthma management. Telemedicine offers substantial opportunities for improved asthma care of patients across the full range of socioeconomic strata. Ever-improving digital tools for asthma assessment and treatment are key components of telemedicine platforms for asthma management. These include a variety of remote patient-monitoring devices, digital inhaler systems, and mobile-health applications that facilitate ongoing assessment and adherence to treatment protocols. Digital tools for monitoring treatment focus on tracking medication use, inhalation technique, and physiological markers such as peak-flow rate and pulse-oximetry. Telemedicine visits allow for elements of assessment via video, approximating or duplicating many aspects of in-person visits, such as evaluating a patient's general appearance, breathing effort, and cough. Challenges remain in ensuring equitable access to these technologies, especially in rural and low-income areas, and in maintaining patient privacy and data security in digital platforms.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11405314 | PMC |
http://dx.doi.org/10.3389/falgy.2024.1451768 | DOI Listing |
Proc Natl Acad Sci U S A
September 2025
Department of Medicine, Institute for Transformative Molecular Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106.
The β-adrenergic receptor (βAR), a prototype G protein-coupled receptor, controls cardiopulmonary function underpinning O delivery. Abundance of the βAR is canonically regulated by G protein-coupled receptor kinases and β-arrestins, but neither controls constitutive receptor levels, which are dependent on ambient O. Basal βAR expression is instead regulated by the prolyl hydroxylase/pVHL-E3 ubiquitin ligase system, explaining O responsivity.
View Article and Find Full Text PDFAllergol Immunopathol (Madr)
September 2025
Quirón Dexeus University Hospital, Nevot Casas Paediatric and Family Clinic, Calle Sabino Arana, Barcelona, Spain.
is an ubiquitous mold commonly found in both outdoor and indoor environments. It is a common airborne mold recognized as a significant aeroallergen linked to pediatric allergic rhinitis and asthma. Although sensitization rates in children vary regionally, evidence suggests that allergy significantly impacts pediatric respiratory health and as its exposure worsens, respiratory outcomes in susceptible pediatric populations .
View Article and Find Full Text PDFAllergol Immunopathol (Madr)
September 2025
Department of Respiratory Disease, Children's Hospital Affiliated to Shandong University, Jinan, China.
Background: Asthma is a chronic respiratory disease with complex pathogenesis. Some studies suggest that certain trace metals may be associated with asthma. However, the relationship between serum copper (Cu) and childhood asthma remains unclear.
View Article and Find Full Text PDFAllergol Immunopathol (Madr)
September 2025
Department of Internal Medicine, Bilkent City Hospital, Ankara, Türkiye.
Objective: The aim of this study was to evaluate and compare the prevalence of comorbidities in asthmatic and non-asthmatic individuals and to compare groups based on sociodemographic variables.
Materials And Methods: This cross-sectional study used data from the 2017 National Household Health Survey (NHHS), which included 6053 individuals aged 15 years and older. The sociodemographic characteristics, behavioral risk factors, and comorbidities of the study participants were analyzed and Pearson chi-squared tests were used to assess statistical significance, and multiple logistic regression analysis was conducted to evaluate the relationships.
BMJ Public Health
September 2025
Department of Health Policy and Management, Johns Hopkins University, Baltimore, Maryland, USA.
Background: To synthesise recent empirical evidence for the prevention and management of respiratory function in children.
Methods And Findings: We searched the PubMed, Cochrane Library, Embase and Web of Science databases for studies published from inception to 16 September 2024. Two authors independently selected eligible studies, evaluated the quality of the included studies and assessed bias based on the Cochrane Collaboration tool for assessing the risk of bias.